The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells

Acta Pharmacologica Sinica

Volumn 32, Issue 3, 2011, Pages 354-360

  Zou, Shao Wu ^a   Ai, Kai Xing ^a   Wang, Zhi Gang ^a   Yuan, Zhou ^a   Yan, Jun ^a   Zheng, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

hepatocellular carcinoma; lentivirus vector; Med19; proliferation; RNAi; tumorigenesis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MEDIATOR COMPLEX; MEDIATOR COMPLEX SUBUNIT 19; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; COLONY FORMATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC VECTORS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MEDIATOR COMPLEX; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING;

EID: 79952403533     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.223     Document Type: Article

References (33)

1. Okuda K. Natural history of hepatocellular carcinoma including fbrolamellar and hepato-cholangio carcinoma variants. J Gastroen-terol Hepatol 2002; 17: 401-5. (Pubitemid 34534077)
2. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211
3. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127: S27-34 (Pubitemid 39423367)
4. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35 195-203 (Pubitemid 41079923)
5. Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-87 (Pubitemid 44286000)
6. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8 (Pubitemid 32494397)
7. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Rev Cancer 2003; 3: 453-8 (Pubitemid 37328849)
8. Westhof E, Filipowicz W. From RNAi to epigenomes: how RNA rules the world. Chembiochem 2005; 6: 441-3 (Pubitemid 40879758)
9. Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, et al. A set of consensus mammalian mediator subunits identifed by multidimensional protein identifcation technology Mol Cell 2004 14: 685-91 (Pubitemid 38739090)
10. Kornberg RD. Mediator and the mechanism of transcriptional activa-tion. Trends Biochem Sci 2005; 30: 235-9
11. Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW. The mammalian Mediator complex and its role in transcriptional regula-tion. Trends Biochem Sci 2005; 30: 250-5 (Pubitemid 40693868)
12. Casamassimi A, Napoli C. Mediator complexs and eukaryotic trans-crip tion regulation: An overview. Biochimie 2007; 89: 1439-46 (Pubitemid 350122855)
13. Myers LC, Kornberg RD. Mediator of transcriptional regulation. Annu Rev Biochem 2000; 69: 729-49
14. Baidoobonso SM, Guidi BW, Myers LC. Med19 (Rox3) regulates ntermodule interactions in the Saccharomyces cerevisiae mediator complex. J Biol Chem 2007; 282: 5551-9 (Pubitemid 47093718)
15. Naldini L, Gallay P, Gallay P. In vivo gene delivery and stable trans-duction of nondividing cells by a lentiviral vector. Science 1996; 272 263-7 (Pubitemid 26119138)
16. -ΔΔCT method. Methods 2001; 25: 402-8 (Pubitemid 34164012)
17. Xu Y, Wang Z, Wang J, Li J, Wang H, Yue W. Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Onco Res 2010; 18: 359-64
18. Lengronne A, Pasero P, Bensimon A, Schwob E. Monitoring S phase progression globally and locally using BrdU incorporation in TK+ yeast strains. Nucleic Acids Res 2001; 29: 1433-42 (Pubitemid 32288489)
19. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA RNA interference in adult mice. Nature 2002; 418: 38-9 (Pubitemid 34742563)
20. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20: 1006-10.
21. Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Stürzebecher A Schuster O, et al. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J Biol Chem 2004; 279: 33613-22 (Pubitemid 39063010)
22. D'Alessio S, Margheri F Pucci M, Del Rosso A, Monia BP, Bologna M et al. Antisense oligodeoxynucleotides for urokinase plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int J Cancer 2004; 110: 125-33 (Pubitemid 38507212)
23. Arens N, Gandhari M, Bleyl U, Hildenbrand R. In vitro suppression of urokinase plasminogen activator in breast cancer cells\a comparison of two antisense strategies. Int J Oncol 2005; 26: 113-9.
24. Woessmann W, Damm-Welk C, Fuchs U, Borkhardt A. RNA inter-ference: new mechanisms for targeted treatment? Rev Clin Exp Hematol 2003; 7: 270-91 (Pubitemid 38076175)
25. Jiang M, Rubbi CP, Milner J. Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis Oligonucleotides 2004; 14: 239-48 (Pubitemid 40144362)
26. Rye PD, Stigbrand T. Interfering with cancer: a brief outline of advances in RNA interference in oncology Tumour Biol 2004; 25: 329-36 (Pubitemid 40082339)
27. Wilda M, Fuchs U, Wossmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21: 5716-24
28. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesen- chymal transitions by repressing E-cadherin expression. Nat Cell Bio 2000; 2: 76-83
29. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L Bruyneel E, et al. The two-handed E box binding zinc fnger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-78 (Pubitemid 32607360)
30. Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A The transcription factor Slug represses E-cadherin expression and nduces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116: 499-511 (Pubitemid 36231290)
31. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39 (Pubitemid 38798858)
32. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC Weinberg RA. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006; 103: 18969-74 (Pubitemid 350002812)
33. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007; 104: 10069-74 (Pubitemid 47175264)